|Articles|November 2, 2016

Pharmaceutical Technology

  • Pharmaceutical Technology-11-02-2016
  • Volume 40
  • Issue 11

Standardized Templates Can Help Make the Job Easier

Author(s)Agnes Shanley

In 2009, the International Pharmaceutical Excipients Council introduced an Excipient Information Package that includes a product requirement datasheet, site quality overview, and site and supply chain security overview.

In 2009, the International Pharmaceutical Excipients Council (IPEC) introduced an Excipient Information Package (1) that includes a product requirement datasheet, site quality overview, and site and supply chain security overview, providing a standard format and consistency across suppliers and product lines.“It can save the time usually wasted tracking down individual supplier questionnaires,” said IPEC Chair Priscilla Zawislak in a September 20, 2016 webcast hosted by Pharmaceutical Technology (2). IPEC also offers quality agreement templates (3) for  pharmaceutical manufacturers and excipient suppliers and distributors, and will add templates for manufacturer agreements with both distributors and original manufacturers. 

References

1.

IPEC Excipient Information Package: Template and User Guide

, IPECAmericas.org, 2009.
2. “Best Practices for Effective Excipient Sourcing and Testing,” a Pharmaceutical Technology webcast.
3. IPEC,

The IPEC QA Guide and Template

, IPECAmericas.org.

Article Details

Pharmaceutical Technology
Vol. 40, No. 11
Pages: 60

Citation

When referring to this article, please cite it as A. Shanley, "Standardized Templates Can Help Make the Job Easier,” sidebar to "Managing Risk in Raw Material Sourcing," Pharmaceutical Technology 40 (11) 2016. 


Related to this article

Pharma Logistician Using IoT Based On Blockchain | Image Credit: ©leowolfert -stock.adobe.com
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.
AAPS PharmSci 360: CMC Strategies, Part 3
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discuss the implementation of risk-based approaches for CMC.